![Curtis Patton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Curtis Patton
Nessuna posizione attualmente
Patrimonio netto: 431 308 $ in data 31/08/2026
Profilo
Curtis Patton is currently an Independent Director at Tevogen, Inc. since 2024 and Professor-Emeritus at Yale School of Public Health.
Former positions include Director at Tevogen Bio, Inc. and Head of Global Health at Yale University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
0,95% | 23/07/2026 | 61.792 ( 0,95% ) | 431 308 $ | 31/08/2026 |
Posizioni attive di Curtis Patton
| Società | Posizione | Inizio |
|---|---|---|
Yale School of Public Health
 Yale School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Precedenti posizioni note di Curtis Patton
| Società | Posizione | Fine |
|---|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Tevogen Bio, Inc.
 Tevogen Bio, Inc. BiotechnologyHealth Technology Develops investigational therapies to treat viral infections | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
18
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale School of Public Health
Yale School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tevogen Bio, Inc.
Tevogen Bio, Inc. BiotechnologyHealth Technology Develops investigational therapies to treat viral infections | Health Technology |
